Nectar Lifesciences Share Price

ABOUT Nectar Lifesciences

• Industry Biotechnology & Drugs
• ISIN INE023H01027
• BSE Code 532649
• NSE Code NECLIFE

Nectar Lifesciences Limited is an India-based pharmaceutical company. The Company's business areas include active pharmaceutical ingredients (APIs) and intermediates, formulations/finished dosage formulations (FDF), menthol and mint derivatives, and empty hard gelatin capsules. The Company is engaged in the manufacturing of oral and sterile cephalosporin products. Its oral cephalosporins include cefixime, cefurozime axetil crystalline, cefuroxime axetil amorphous, cedpodoxime proxetil, cefprozil and cefdinir. Its sterile cephalosporins include cefotaxime sodium, ceftriaxone sodium, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate and cefepime arginine. Its capacities include cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium and ceftriaxone sodium. The Company offers contract manufacturing capabilities for solid dosage forms, such as tablets, capsules, dry powder oral suspension and granules and injectable for cephalosporins.

MANAGEMENT

• Sanjiv Goyal Executive Chairman of the Board, Managing Director
• Amit Chadah Chief Executive Officer
• Sushil Kapoor Chief Financial Officer
• Neha Vaishnav Chief Compliance Officer, Company Secretary
• Puneet Sud Additional Director, Wholetime Director - Operations